Fig. 2: Identification of frequent methylation in the promoter region of RASA4 in SCLC.

A The workflow of the integrated analysis of MeDIP-seq data of plasma cfDNA and tissue DNA. B KEGG analysis of genes associated with the 154 shared DMRs. C Methylation peaks of the DMR (Chr7: 102254100-102244400) within the RASA4 promoter in plasma cfDNA and tissue DNA, as determined by MeDIP-seq. D The DMR (Chr7: 102,254,100-102,244,400) contains binding sites for transcription factors TFAP2A and RUNX1, predicted in the JASPAR database. E BSP analysis of the CpG sites in the DMR (Chr7: 102254100-102244400) within the RASA4 promoter in 10 paired SCLC tumor and adjacent normal tissues. The data are shown as mean ± SD from 10 SCLC patients (n = 10, paired Student’s t-test).